Discovery & formulation
Actives strategy, INCI architecture, safety narratives, stability plans, and tech transfers that regulators can follow.
B2B programs
We engage through governed scopes — co-development, ODM, or OEM — each mapped to the same full-chain operating model described under Operations. Pick an entry path, scan capabilities, then see who we typically serve and how programs land in practice.
How we engage
Choose the commercial shape that fits your brand — technical milestones, documentation, and owners stay consistent across paths.
Joint discovery through registration-ready dossiers: formulation, claims architecture, stability, and batch genealogy owned together under a single program office — ideal when you need differentiated science and shared IP discipline.
We develop and industrialize under your identity with transparent formula custody and change control — go deeper on scope boundaries in ODM vs OEM below.
Manufacturing and release against agreed specifications with audit-ready records — suited when formulation is fixed and you need predictable scale, QC rhythm, and export-ready paperwork.
Commercial models
Both run on the same quality system — the difference is where creative and regulatory narrative responsibility sits.
Need a hybrid? Many programs start co-development, then narrow to OEM for line extensions — talk to commercial about phase gates.
Capability matrix
A concise checklist — each line maps to owners under Operations for detail.
Actives strategy, INCI architecture, safety narratives, stability plans, and tech transfers that regulators can follow.
Medical-cosmetic-grade line discipline, validated processes, and batch records sized for inspection dialogue.
Incoming through finished goods testing treated as one continuous risk surface — not a final checkbox.
Roadmaps, milestones, and commercials aligned with technical reality — governance before SKU counts.
Named threads for tech questions, change control, and post-market rhythm across regions.
Early review of packaging and contracts so filings and retail listings share one narrative.
Who we serve
Representative segments — programs always start with a scoped discovery, not a catalogue SKU.
Clinic-grade lines seeking compliant storytelling and repeatable batch quality.
Partners who need export packs, COAs, and registration-friendly dossiers on schedule.
Teams expanding into companion topicals with shared governance expectations.
Structured stage-gates, audit trails, and steering-ready reporting for corporate stakeholders.
Evidence of shape
Short illustrations of how milestones land — open a sample article layout or jump to Contact for a comparable discussion.
Cross-functional reformulation, claims tightening, and stability bridging across two hero SKUs.
Read snapshotSingle program office for artwork, batch records, and trainer-facing scientific FAQs.
Read snapshotLocked specs, quarterly stability lanes, and documentation packs tuned for distributor registration.
Similar briefShare where your program sits (discovery, scale-up, or release). We respond with owners, artifacts, and a realistic sequence across Operations.